Modulation of lerk-2-mediated cell adhesion

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) C07K 14/52 (2006.01) C07K 16/28 (2006.01) G01N 33/50 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2308126

Methods of modulating LERK-2-mediated cell adhesion, as well as methods of modulating angiogenesis and inflammation are described. Also described are agents such as antibodies which can modulate LERK-2 mediated cell adhesion, as well as methods of treating angiogenic diseases and inflammatory diseases.

L'invention porte sur des procédés de modulation de l'adhésion cellulaire induite par la LERK-2, et des procédés de modulation de l'angiogenèse et de l'inflammation, sur des agents tels que des antibiotiques pouvant moduler l'adhésion cellulaire induite par la LERK-2, et sur des procédés de traitement des maladies angiogènes et inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulation of lerk-2-mediated cell adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of lerk-2-mediated cell adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of lerk-2-mediated cell adhesion will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1718049

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.